Automated Liquid-Chromatographic Analyzer Used for Toxicology Screening in a General Hospital: 12 Months' Experience (Drug Monitoring and Toxicology) Automated Liquid-Chromatographic Analyzer Used for Toxicology Screening in a General Hospital: 12 Months' Experience (Drug Monitoring and Toxicology)

Automated Liquid-Chromatographic Analyzer Used for Toxicology Screening in a General Hospital: 12 Months' Experience (Drug Monitoring and Toxicology‪)‬

Clinical Chemistry 1997, March, 43, 3

Clinical Chemistry
    • 2,99 €
    • 2,99 €

Publisher Description

For toxicological screening during acute drug poisoning, laboratories must implement rapid and specific methods. Many laboratories use broad-spectrum screening to determine unknown agents in a patient's sample. Several studies have shown that toxicological screening frequently identifies unsuspected drugs in patients with drug overdoses [1,2]. In a majority of cases, all that is required to guide therapy is qualitative drug screening. Some authors have developed methods for toxicological screening [3,4] based on thin-layer chromatography (TLC) separation and ultraviolet (UV) spectral detection, respectively. (3) Toxi-Lab (Irvine, CA) has developed a drug-screening procedure based on liquid-liquid extraction, TLC separation, and reagent-spray detection (sulfuric acid, Draggendorf reagent).

GENRE
Science & Nature
RELEASED
1997
1 March
LANGUAGE
EN
English
LENGTH
16
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
223.1
KB

More Books Like This

Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring
Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring
2012
Standards of Laboratory Practice: Analgesic Drug Monitoring (Nacb Symposium) Standards of Laboratory Practice: Analgesic Drug Monitoring (Nacb Symposium)
Standards of Laboratory Practice: Analgesic Drug Monitoring (Nacb Symposium)
1998
Therapeutic Drug Monitoring in Special Populations (Tdm Conference) Therapeutic Drug Monitoring in Special Populations (Tdm Conference)
Therapeutic Drug Monitoring in Special Populations (Tdm Conference)
1998
Drug Disposition and Pharmacokinetics Drug Disposition and Pharmacokinetics
Drug Disposition and Pharmacokinetics
2011
Safety of St. John's Wort Extract Compared to Synthetic Antidepressants (Review) Safety of St. John's Wort Extract Compared to Synthetic Antidepressants (Review)
Safety of St. John's Wort Extract Compared to Synthetic Antidepressants (Review)
2006
Urinary Cannabinoid Detection Times After Controlled Oral Administration of [[Delta].Sup.9]-Tetrahydrocannabinol to Humans (Drug Monitoring and Toxicology) (Clinical Report) Urinary Cannabinoid Detection Times After Controlled Oral Administration of [[Delta].Sup.9]-Tetrahydrocannabinol to Humans (Drug Monitoring and Toxicology) (Clinical Report)
Urinary Cannabinoid Detection Times After Controlled Oral Administration of [[Delta].Sup.9]-Tetrahydrocannabinol to Humans (Drug Monitoring and Toxicology) (Clinical Report)
2003

More Books by Clinical Chemistry

Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report) Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report)
Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report)
2002
Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs) Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs)
Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs)
2004
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report) Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report)
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report)
2001
A Conversation with Elizabeth Blackburn (Interview) A Conversation with Elizabeth Blackburn (Interview)
A Conversation with Elizabeth Blackburn (Interview)
2009
The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective) The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective)
The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective)
1998